Globus Medical
GMED · NYSE · Healthcare
$73.96
$0.33 (-0.44%) today
Market Cap
$9.93B
24h Volume
$107.7M
P/E Ratio
18.9
52w High
$96.82
52w Low
$55.10
Est. AI Revenue
22%
7-Day Sparkline (Static)
Company facts
Performance
About Globus Medical
Globus Medical is a musculoskeletal device company. It makes money selling spine implants, orthopedic hardware, and surgical technology to hospitals and surgery centers, with robotic systems used to guide procedures and pull through implant sales.
Its AI-related line centers on the ExcelsiusGPS robotic navigation system, which supports AI-assisted spine surgery. Around it sit AI surgical planning tools, imaging-based AI navigation, and robotic spine software that help surgeons place implants with more precision.
Founded in 2003 and headquartered in Audubon, Pennsylvania, Globus Medical trades on the NYSE and employs about 6,000 people.
Globus Medical in the AI buildout
Globus Medical sits in the AI Healthcare and Robotics & Automation layers of the AI buildout. Its ExcelsiusGPS robot brings AI-assisted navigation into spine and orthopedic operating rooms, and robot adoption helps sell more implants alongside it. That makes robotics a genuine growth lever for the company. Most revenue, though, still comes from conventional musculoskeletal hardware, so its AI exposure is a meaningful slice of the business rather than the core of it.
GMED is tracked in AI Healthcare and Robotics & Automation, rated Peripheral on the AI Exposure leaderboard.
By the numbers
52-week range
GMED trades at $73.96, 45% of the way up its 52-week range of $55.10 to $96.82.
Market cap
Market capitalization is $9.93B, with an AI Exposure Score of 20 out of 100.
Valuation vs peers
Its P/E ratio of 18.9 is below the AI Healthcare category median of 29.6.
Next earnings
Globus Medical is next expected to report earnings on November 5, 2026.
Market data as of the close on . Prices are end of day, not live.
Frequently asked questions
What does Globus Medical do?
Globus Medical sells spine implants, orthopedic hardware, and surgical technology to hospitals. Its ExcelsiusGPS robotic navigation system supports AI-assisted spine and orthopedic surgery and helps drive sales of the implants used in those procedures.
How is Globus Medical exposed to AI?
Mainly through surgical robotics. The ExcelsiusGPS robot, AI surgical planning, and imaging AI navigation are growth drivers, but most revenue is conventional implant hardware. Supercycle rates it an AI Exposure Score of 20 out of 100.
What are Globus Medical's main products?
Spine implants and orthopedic hardware, plus the ExcelsiusGPS robotic navigation system. Supporting technology includes AI surgical planning, imaging AI navigation, and robotic spine software used in AI-assisted procedures.
What sector and categories is GMED in?
Globus Medical is in the Healthcare sector. On Supercycle it is categorized under AI Healthcare and Robotics & Automation, reflecting its robotic surgical systems for spine and orthopedic procedures.
Where is Globus Medical based and who leads it?
Globus Medical is headquartered in Audubon, Pennsylvania, and is led by CEO Keith W. Pfeil. The company was founded in 2003 and employs about 6,000 people.
Profile written 2026-08, updated as the business changes. Editorial content, not investment advice.